{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:14:25Z","timestamp":1778163265758,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.transproceed.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:40:06Z","timestamp":1776512406000},"page":"816-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation"],"prefix":"10.1016","volume":"58","author":[{"given":"Yakub","family":"Patat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl\u015fah","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Keklik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylag\u00fcl","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.03.015_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-78580-6_1","article-title":"Principles and overview of allogeneic hematopoietic stem cell transplantation","volume":"144","author":"Giralt","year":"2009","journal-title":"Cancer Treat Res"},{"issue":"4","key":"10.1016\/j.transproceed.2026.03.015_bib0002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/bmt.2014.300","article-title":"Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT","volume":"50","author":"Sauer","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2026.03.015_bib0003","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bbmt.2019.04.013","article-title":"Levofloxacin versus cefpodoxime for antibacterial prophylaxis in allogeneic stem cell transplantation","volume":"25","author":"Doan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2026.03.015_bib0004","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/bmt.2010.286","article-title":"Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients","volume":"46","author":"Liu","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2026.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bmt.2016.66","article-title":"Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation","volume":"51","author":"Weber","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2026.03.015_bib0006","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bbmt.2019.04.013","article-title":"Levofloxacin versus cefpodoxime for antibacterial prophylaxis in allogeneic stem cell transplantation","volume":"25","author":"Doan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2026.03.015_bib0007","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","article-title":"Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation","volume":"23","author":"Weber","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.03.015_bib0008","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3947\/ic.2022.0005","article-title":"Bacteremia in hematopoietic stem cell recipients receiving fluoroquinolone prophylaxis: incidence, resistance, and risk factors","volume":"54","author":"Eryilmaz-Eren","year":"2022","journal-title":"Infect Chemother"},{"issue":"12","key":"10.1016\/j.transproceed.2026.03.015_bib0009","doi-asserted-by":"crossref","first-page":"1195.e1","DOI":"10.1016\/j.jtct.2024.09.011","article-title":"Antibiotic prophylaxis during allogeneic stem cell transplantation\u2014a comprehensive single center retrospective analysis","volume":"30","author":"Neuerburg","year":"2024","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:42:17Z","timestamp":1778161337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0041134526001715"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.03.015","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}